Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Photo: Getty Images

Driven by the developmental and retail costs of specialty drugs and a less-than-robust generic drug market, pharmaceutical price increases will move into the double-digit range by 2016.

That’s what an analysis of cost factors by Aon Hewitt forecasts. The results emerged from an actuarial analysis of medical trend cost information from various sources, from client experience, government sources and carriers to third-party sources, Aon Hewitt said. 

Dan Cook

Dan Cook is a journalist and communications consultant based in Portland, OR. During his journalism career he has been a reporter and editor for a variety of media companies, including American Lawyer Media, BusinessWeek, Newhouse Newspapers, Knight-Ridder, Time Inc., and Reuters. He specializes in health care and insurance related coverage for BenefitsPRO.

More from this author



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO
Live Chat

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.